Are insiders buying RPHM stock?

Yes — 2 distinct insiders have bought RPHM (Reneo Pharmaceuticals, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Sep 26, 2024.

How much RPHM stock have insiders bought?

Insiders have bought a combined $1.6M of RPHM across 9 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in RPHM?

A cluster buy is two or more distinct Reneo Pharmaceuticals, Inc. insiders — officers, directors, or 10% owners — each buying RPHM on the open market within a rolling window. RPHM has 1 detected cluster buy to date.

Where does this RPHM insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

RPHM insider buying

1 cluster buy

Reneo Pharmaceuticals, Inc.

When two or more insiders at Reneo Pharmaceuticals, Inc. buy RPHM in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in RPHM plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$1.6M

Market cap

Unknown

Detected clusters

Aug 13 – Sep 25, 2024
Detected Sep 25, 2024
2 insiders
Total bought
$992.5K
Market cap
Unknown

All notable open-market buys in RPHM

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Sep 25, 2024	Leonard Braden Michaelcluster 10% Owner	68,746	$1.50	$103.1K	SEC ↗
Sep 18, 2024	Leonard Braden Michaelcluster 10% Owner	806	$1.40	$1.1K	SEC ↗
Sep 17, 2024	Leonard Braden Michaelcluster 10% Owner	55,300	$1.36	$75.2K	SEC ↗
Sep 16, 2024	Leonard Braden Michaelcluster 10% Owner	172,747	$1.37	$236.7K	SEC ↗
Sep 13, 2024	Leonard Braden Michaelcluster 10% Owner	150,000	$1.31	$196.5K	SEC ↗
Aug 14, 2024	Leonard Braden Michaelcluster 10% Owner	100,487	$1.41	$141.7K	SEC ↗
Aug 13, 2024	Leonard Braden Michaelcluster 10% Owner	171,339	$1.39	$238.2K	SEC ↗
May 14, 2024	Leonard Braden Michael 10% Owner	335,000	$1.54	$515.9K	SEC ↗
May 14, 2024	Leonard Braden Michael 10% Owner	79,281	$1.56	$123.7K	SEC ↗

RPHM insider buying — FAQ

Are insiders buying RPHM stock?: Yes — 2 distinct insiders have bought RPHM (Reneo Pharmaceuticals, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Sep 26, 2024.
How much RPHM stock have insiders bought?: Insiders have bought a combined $1.6M of RPHM across 9 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in RPHM?: A cluster buy is two or more distinct Reneo Pharmaceuticals, Inc. insiders — officers, directors, or 10% owners — each buying RPHM on the open market within a rolling window. RPHM has 1 detected cluster buy to date.
Where does this RPHM insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in RPHM

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy RPHM within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding RPHM.